May 1st 2025
Capan discusses the collaboration between AWS and EVERSANA in the first part of this two-part interview.
Sheeran continues the conversation on the collaboration between AWS and EVERSANA in the second part of this interview.
April 29th 2025
April 24th 2025
AI is transforming content reviews to focus on relevant use, not just generation.
April 17th 2025
How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.
FDA Violation Letters at All-Time Low in 2015
January 2011, 2016.
Shire to Buy Baxalta for $32 Billion
January 11, 2016.
Toward JP Morgan 2016: Pharm Exec's Top Tweets
January 08, 2016.
FDA: More “Me-Betters” and Focused Breakthroughs
January 05, 2016.
Brazil Approval for Sanofi's Dengue Vaccine
January 07, 2016.
Priority Review Vouchers Raise Risks, say FDA Officials
January 06, 2016.
mAbs to Watch in 2016
Global Breast Cancer Treatment Market to Reach $17.2 Billion by 2021
Pfizer Depression Candidate Fails in Phase 3 Study
January 04, 2016.
UK Cancer Drug Discovery Database Goes 3D
KaloBios Files for Bankruptcy Following Shkreli Arrest
FDA Grants Priority Review Status to Cholera Vaccine
December 23, 2015.
EMA Spells Out Plan for Trial Portal and Database
Amgen Buys Medigene Spin-Off Company Catherex
Gastric Cancer Treatment Market to Expand Rapidly to $4.4 Billion by 2024
December 22, 2015.
Lilly Slaps $8,000-Per-Treatment-Cycle Price Tag On Lung Cancer Drug
December 21, 2015.
Turing Announces Shkreli Resignation, Appoints Interim CEO
The Center for Drug Evaluation's Long To-Do List for 2016
December 18, 2015.
Retrophin Issues Statement on Indictment of Martin Shkreli
High Prevalence, Not Sales, to Drive Pancreatic Treatment Market to $2.9 Billion by 2021
Isis Pharmaceuticals Changes Company Name
Last Call To Enter 4A’s 2016 Partner Award in Health & Wellness
December 14, 2015.
AstraZeneca Agrees to Buy 55 Percent of Acerta Pharma
December 17, 2015.
Top Pharma Companies’ R&D Returns Continue to Slide, Says Study
Turing's Martin Shkreli Arrested
Transatlantic Cancer Collaboration Seeks to Accelerate Early Detection
December 15, 2015.
Sanofi and Boehringer Ingelheim in Business-Swap Agreement
Valeant Announces New Fulfillment Agreements With Walgreens
Deals Crucial to Offsetting $2.5 Billion Cost of Developing a Novel Drug, says Report
Mergers, Pricing, and New Technologies: The Top Health Issues of 2016